facebook

Eye Freckles in Young Patients: Special Considerations for Iris and Choroidal Naevi Under 40

3 min read

In younger patients, the clinical priority is excellent baseline documentation and a clear monitoring plan, because a longer lifetime horizon makes long-term surveillance more relevant. ²

For iris naevi, age ≤40 years is part of the ABCDEF framework for higher risk of growth into melanoma (in a tertiary ocular oncology cohort). ¹ That does not mean most young patients develop melanoma, it means clinicians should be meticulous about:

  • slit-lamp photography (size, margins, configuration)
  • checking for hyphema, ectropion uveae, diffuse spread, or angle involvement
  • documenting change over time

For choroidal naevi, many lesions discovered in younger adults are benign. The key is to avoid both extremes: dismissal without imaging and over-referral without risk features. Photography and OCT help detect subtle fluid or retinal change, and ultrasound can quantify thickness when needed. ³

At Blue Fin Vision®, young patients are managed with structured imaging, explicit documentation of risk features, and follow-up intervals based on objective findings rather than reassurance alone.

References

  1. Shields CL, Kaliki S, Hutchinson A, Nickerson S, Patel J, Kancherla S, et al. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide. Ophthalmology. 2013;120(4):766-772. doi:10.1016/j.ophtha.2012.10.041. PMID: 23290981.
  2. Chien JL, Sioufi K, Surakiatchanukul T, Shields JA, Shields CL. Choroidal nevus: a review of prevalence, features, genetics, risks, and outcomes. Current Opinion in Ophthalmology. 2017;28(3):228-237. doi:10.1097/ICU.0000000000000361. PMID: 28141766.
  3. Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Archives of Ophthalmology. 2009;127(8):981-987. doi:10.1001/archophthalmol.2009.151. PMID: 19667334.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.